The majority of patients in the gastric adenocarcinoma cohort study of TCGA (240 of 440 patients or 54.5%) had an up-regulation of CDX2 (mRNA expression z score compared with normal samples above zero). The gene discussed is CDX2; the disease is gastric adenocarcinoma.